Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

FDG-PET/CT radiomics for survival prediction in patients with rectal cancer treated with surgery

Masatoshi Hotta, Ryogo Minamimoto, Yoshimasa Gohda and Hideaki Yano
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 212;
Masatoshi Hotta
2Nuclear Medicine National Center for Global Health and Medicine Tokyo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryogo Minamimoto
1National Center for Global Health and Medicine Tokyo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshimasa Gohda
3Surgery National Center for Global Health and Medicine Tokyo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideaki Yano
3Surgery National Center for Global Health and Medicine Tokyo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

212

Purpose: To investigate the usefulness of radiomics with machine learning using FDG-PET/CT in patients with rectal cancer. Materials and Methods: A total of 103 patients (male:female = 74:29, age: 65.4±12.1 years) with rectal cancer who had been treated with surgery (± neoadjuvant therapy) were retrospectively reviewed and allocated to training and test data sets (2:1 ratio). The volume of interest of the primary tumor was semi-automatically defined with a threshold of 40% of the maximum standardized uptake value, and radiomic features including global, local, and regional textural features were extracted. A random survival forest (RSF) model for predicting overall survival (OS) was trained with 1) radiomic features and 2) clinical profiles. The performance of RSF model was evaluated with Kaplan-Meier analysis with log rank test, and integrated area under the receiver operating characteristic curve (iAUC).

Results: The median follow-up of the patients was 943 days. The radiomic RSF model appropriately stratified patients from the test set into low-risk and high-risk groups of poor prognoses (log-rank p=0.007, hazard ratio: 10.2). The GLCM_ Dissimilarity was the most relevant radiomic feature by the variable-hunting algorithm of the RSF model. The RSF model of radiomics were successfully validated on the test set respectively (iAUC=0.67), and the combination of radiomics and clinical RSF model showed higher survival prediction (iAUC=0.78).

Conclusions: Radiomics with machine learning using FDG-PET/CT have a potential for predicting overall survival in rectal cancer, which diagnostic value can be increased by integration with clinical profiles.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
FDG-PET/CT radiomics for survival prediction in patients with rectal cancer treated with surgery
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
FDG-PET/CT radiomics for survival prediction in patients with rectal cancer treated with surgery
Masatoshi Hotta, Ryogo Minamimoto, Yoshimasa Gohda, Hideaki Yano
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 212;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
FDG-PET/CT radiomics for survival prediction in patients with rectal cancer treated with surgery
Masatoshi Hotta, Ryogo Minamimoto, Yoshimasa Gohda, Hideaki Yano
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 212;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Assessment of incidental pituitary uptake on FDG PET/CT scan: Digital vs. conventional PET/CT
  • Zero TE-based PET/MR attenuation correction in patients with oral cavity cancer
Show more Oncology: Clinical Therapy and Diagnosis

GI – Colorectal, Liver, Esophageal

  • Prediction of 90Y selective internal radiation therapy outcome using pre-therapeutic biomarkers in unresectable and refractory intra-hepatic cholangiocarcinoma patients
  • The prognostic value of 68Ga-DOTATOC-PET/CT and 18F-FDG-PET/CT in patients with liver metastases of pancreatic neuroendocrine tumors: A comparison with CT or MRI
  • Lowering threshold to 15% for early metabolic response assessment using 18F-FDG PET/CT in metastatic colorectal cancer: results from prospective studies with external validation cohort
Show more GI – Colorectal, Liver, Esophageal

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire